Cosmo Pharmaceuticals NV COSMO PH.../ NL0011832936 /
5/24/2024 4:22:36 PM | Chg. - | Volume | Bid6:00:04 AM | Ask6:00:04 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
71.90CHF | - | 1,187 Turnover: 85,345.30 |
-Bid Size: - | -Ask Size: - | 1.29 bill.CHF | - | - |
GlobeNewswire
8/21
Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation ...
GlobeNewswire
8/21
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
GlobeNewswire
8/19
Qubit Pharmaceuticals nominated for "Best start-up" award at Prix Galien USA 2024
GlobeNewswire
8/16
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYS...
GlobeNewswire
8/16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
8/15
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
8/14
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of...
GlobeNewswire
8/13
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film...
GlobeNewswire
8/13
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Busine...
GlobeNewswire
8/12
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
GlobeNewswire
8/12
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
GlobeNewswire
8/8
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire
8/7
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
8/7
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corpora...
GlobeNewswire
8/7
World’s largest packaging and processing event has selected unique bible paper product as a finalist...
GlobeNewswire
8/5
DEADLINE ALERT for MRNS, and SMG: The Law Offices of Frank R. Cruz Reminds Investors of Class Action...
GlobeNewswire
8/5
TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc...
GlobeNewswire
8/2
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marinus
GlobeNewswire
8/2
MRNS DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors w...
GlobeNewswire
8/1
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update